Streptavidin-biotin technology: Improvements and innovations in chemical and biological applications

Applied Microbiology and Biotechnology

Volumn 97, Issue 21, 2013, Pages 9343-9353

  Dundas, Christopher M ^a   Demonte, Daniel ^a   Park, Sheldon ^a  

^a the State University of New York   (United States)

Author keywords

Biotinylation; Enzyme; Protein design; Proteomics; Streptavidin

Indexed keywords

BIOTINYLATIONS; CHEMICAL AND BIOLOGICALS; MOLECULAR SCIENCE; NEW APPLICATIONS; PROTEIN DESIGN; PROTEOMICS; STREPTAVIDIN; STREPTAVIDIN-BIOTIN INTERACTION;

ACYLATION; CHEMICAL STABILITY; COENZYMES; CYTOLOGY; DRUG DELIVERY; ENZYMES; MOLECULAR BIOLOGY;

PROTEINS;

BIOTIN; STREPTAVIDIN; VIRUS VECTOR;

BIOTECHNOLOGY; CATALYSIS; DESIGN; DRUG; EXPERIMENTAL DESIGN; HOMOLOGY; MOLECULAR ANALYSIS; PROTEIN; PROTEOMICS; STABILIZATION;

ARTICLE; BINDING AFFINITY; BIOTINYLATION; CELL ENGINEERING; CELL SURFACE; DRUG BINDING SITE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENZYME ACTIVITY; MASS SPECTROMETRY; MOLECULARLY TARGETED THERAPY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS;

BIOTECHNOLOGY; BIOTIN; CHEMISTRY; DRUG DELIVERY SYSTEMS; MOLECULAR BIOLOGY; PROTEIN BINDING; STAINING AND LABELING; STREPTAVIDIN;

EID: 84886924664     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-013-5232-z     Document Type: Article

References (92)

1. Andrianantoandro E, Basu S, Karig DK, Weiss R (2006) Synthetic biology: new engineering rules for an emerging discipline. Mol Syst Biol 2:2006.0028
2. Aslan FM, Yu Y, Vajda S, Mohr SC, Cantor CR (2007) Engineering a novel, stable dimeric streptavidin with lower isoelectric point. J Biotechnol 128(2):213-225
3. Barry MA, Campos SK, Ghosh D, Adams KE, Mok H, Mercier GT, Parrott MB (2003) Biotinylated gene therapy vectors. Expert Opin Biol Ther 3(6):925-940
4. Bayer EA, Wilchek M (1980) The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal 26:1-45
5. Bing T, Yang X, Mei H, Cao Z, Shangguan D (2010) Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. Bioorg Med Chem 18(5):1798-1805
6. Chauhan A, Tikoo A, Kapur AK, Singh M (2007) The taming of the cell penetrating domain of the HIV Tat: myths and realities. J Control Release 117(2):148-162
7. Chen I, Howarth M, Lin W, Ting AY (2005) Site-specific labeling of cell surface proteins with biophysical probes using biotin ligase. Nat Methods 2(2):99-104
8. Chen MH, Soda Y, Izawa K, Kobayashi S, Tani K, Maruyama K, Tojo A, Asano S (2013) A versatile drug delivery system using streptavidin-tagged pegylated liposomes and biotinylated biomaterials. Int J Pharm 24(13):00540-00541
9. Chilkoti A, Stayton PS (1995) Molecular-origins of the slow streptavidin-biotin dissociation kinetics. J Am Chem Soc 117(43):10622-10628
10. Chilkoti A, Schwartz BL, Smith RD, Long CJ, Stayton PS (1995) Engineered chimeric streptavidin tetramers as novel tools for bioseparations and drug delivery. Biotechnology (NY) 13(11):1198-1204
11. Chivers CE, Crozat E, Chu C, Moy VT, Sherratt DJ, Howarth M (2010) A streptavidin variant with slower biotin dissociation and increased mechanostability. Nat Methods 7(5):391-393
12. Collot J, Gradinaru J, Humbert N, Skander M, Zocchi A, Ward TR (2003) Artificial metalloenzymes for enantioselective catalysis based on biotin-avidin. J Am Chem Soc 125(30):9030-9031
13. de Boer E, Rodriguez P, Bonte E, Krijgsveld J, Katsantoni E, Heck A, Grosveld F, Strouboulis J (2003) Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A 100(13):7480-7485
14. Demonte D, Drake EJ, Lim KH, Gulick AM, Park S (2013) Structure-based engineering of streptavidin monomer with a reduced biotin dissociation rate. Proteins 81(9):1621-1633
15. Emerman AB, Zhang ZR, Chakrabarti O, Hegde RS (2010) Compartment- restricted biotinylation reveals novel features of prion protein metabolism in vivo. Mol Biol Cell 21(24):4325-4337
16. Fahrer J, Schweitzer B, Fiedler K, Langer T, Gierschik P, Barth H (2013) C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein p53 into tumor cells. Bioconjug Chem 24(23506195):595-603
17. Fernandez-Suarez M, Chen TS, Ting AY (2008) Protein-protein interaction detection in vitro and in cells by proximity biotinylation. J Am Chem Soc 130(29):9251-9253
18. Golynskiy MV, Seelig B (2010) De novo enzymes: from computational design to mRNA display. Trends Biotechnol 28(7):340-345
19. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17(10):994-999
20. Helppolainen SH, Nurminen KP, Maatta JA, Halling KK, Slotte JP, Huhtala T, Liimatainen T, Yla-Herttuala S, Airenne KJ, Narvanen A, Janis J, Vainiotalo P, Valjakka J, Kulomaa MS, Nordlund HR (2007) Rhizavidin from Rhizobium etli: the first natural dimer in the avidin protein family. Biochem J 405(3):397-405
21. Howarth M, Chinnapen DJ, Gerrow K, Dorrestein PC, Grandy MR, Kelleher NL, El-Husseini A, Ting AY (2006) A monovalent streptavidin with a single femtomolar biotin binding site. Nat Methods 3(4):267-273
22. Hsu CK, Park S (2010) Computational and mutagenesis studies of the streptavidin native dimer interface. J Mol Graph Model 29(3):295-308
23. Huberman T, Eisenberg-Domovich Y, Gitlin G, Kulik T, Bayer EA, Wilchek M, Livnah O (2001) Chicken avidin exhibits pseudo-catalytic properties. Biochemical, structural, and electrostatic consequences. J Biol Chem 276(34):32031-32039
24. Hyster TK, Knorr L, Ward TR, Rovis T (2012) Biotinylated Rh(III) complexes in engineered streptavidin for accelerated asymmetric C-H activation. Science 338(23112327):500-503
25. Josephson L, Tung CH, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10(2):186-191
26. Khidekel N, Ficarro SB, Clark PM, Bryan MC, Swaney DL, Rexach JE, Sun YE, Coon JJ, Peters EC, Hsieh-Wilson LC (2007) Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. Nat Chem Biol 3(6):339-348
27. Kho Y, Kim SC, Jiang C, Barma D, Kwon SW, Cheng J, Jaunbergs J, Weinbaum C, Tamanoi F, Falck J, Zhao Y (2004) A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. Proc Natl Acad Sci U S A 101(34):12479-12484
28. Kim J, Cantor AB, Orkin SH, Wang J (2009) Use of in vivo biotinylation to study protein-protein and protein-DNA interactions in mouse embryonic stem cells. Nat Protoc 4(4):506-517
29. Kohler V, Mao J, Heinisch T, Pordea A, Sardo A, Wilson YM, Knorr L, Creus M, Prost JC, Schirmer T, Ward TR (2011) OsO4.streptavidin: a tunable hybrid catalyst for the enantioselective cis-dihydroxylation of olefins. Angew Chem Int Ed Engl 50(46):10863-10866
30. Kohler V, Wilson YM, Durrenberger M, Ghislieri D, Churakova E, Quinto T, Knorr L, Haussinger D, Hollmann F, Turner NJ, Ward TR (2013) Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes. Nat Chem 5(2):93-99
31. Laitinen OH, Nordlund HR, Hytonen VP, Kulomaa MS (2007) Brave new (strept)avidins in biotechnology. Trends Biotechnol 25(6):269-277
32. Lau PN, Cheung P (2013) Elucidating combinatorial histone modifications and crosstalks by coupling histone-modifying enzyme with biotin ligase activity. Nucleic Acids Res 41(3):20
33. Lesch HP, Kaikkonen MU, Pikkarainen JT, Yla-Herttuala S (2010) Avidin-biotin technology in targeted therapy. Expert Opin Drug Deliv 7(5):551-564
34. Letondor C, Humbert N, Ward TR (2005) Artificial metalloenzymes based on biotin-avidin technology for the enantioselective reduction of ketones by transfer hydrogenation. Proc Natl Acad Sci U S A 102(13):4683-4687
35. Lim KH, Huang H, Pralle A, Park S (2011) Engineered streptavidin monomer and dimer with improved stability and function. Biochemistry 50(40):8682-8691
36. Lim KH, Hwang I, Park S (2012) Biotin-assisted folding of streptavidin on the yeast surface. Biotechnol Prog 28(1):276-283
37. Lim KH, Huang H, Pralle A, Park S (2013) Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection. Biotechnol Bioeng 110(1):57-67
38. Maatta JA, Helppolainen SH, Hytonen VP, Johnson MS, Kulomaa MS, Airenne TT, Nordlund HR (2009) Structural and functional characteristics of xenavidin, the first frog avidin from Xenopus tropicalis. BMC Struct Biol 9:63
39. Martell JD, Deerinck TJ, Sancak Y, Poulos TL, Mootha VK, Sosinsky GE, Ellisman MH, Ting AY (2012) Engineered ascorbate peroxidase as a genetically encoded reporter for electron microscopy. Nat Biotechnol 30(11):1143-1148
40. Marttila AT, Laitinen OH, Airenne KJ, Kulik T, Bayer EA, Wilchek M, Kulomaa MS (2000) Recombinant NeutraLite avidin: a non-glycosylated, acidic mutant of chicken avidin that exhibits high affinity for biotin and low non-specific binding properties. FEBS Lett 467(1):31-36
41. Meir A, Helppolainen SH, Podoly E, Nordlund HR, Hytonen VP, Maatta JA, Wilchek M, Bayer EA, Kulomaa MS, Livnah O (2009) Crystal structure of rhizavidin: insights into the enigmatic high-affinity interaction of an innate biotin-binding protein dimer. J Mol Biol 386(2):379-390
42. Meir A, Bayer EA, Livnah O (2012) Structural adaptation of a thermostable biotin-binding protein in a psychrophilic environment. J Biol Chem 287(22):17951-17962
43. Morizono K, Xie Y, Helguera G, Daniels TR, Lane TF, Penichet ML, Chen IS (2009) A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. J Gene Med 11(8):655-663
44. Nguyen UTT, Guo Z, Delon C, Wu YW, Deraeve C, Fraenzel B, Bon RS, Blankenfeldt W, Goody RS, Waldmann H, Wolters D, Alexandrov K (2009) Analysis of the eukaryotic prenylome by isoprenoid affinity tagging. Nat Chem Biol 5(4):227-235
45. Nordlund HR, Hytonen VP, Horha J, Maatta JA, White DJ, Halling K, Porkka EJ, Slotte JP, Laitinen OH, Kulomaa MS (2005) Tetravalent single-chain avidin: from subunits to protein domains via circularly permuted avidins. Biochem J 392(Pt 3):485-491
46. Ong SE, Mann M (2005) Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1(5):252-262
47. O'Sullivan VJ, Barrette-Ng I, Hommema E, Hermanson GT, Schofield M, Wu S-C, Honetschlaeger C, Ng KKS, Wong S-L (2012) Development of a tetrameric streptavidin mutein with reversible biotin binding capability: engineering a mobile loop as an exit door for biotin. PLoS ONE 7(4):e35203
48. Paganelli G, Grana C, Chinol M, Cremonesi M, De Cicco C, De Braud F, Robertson C, Zurrida S, Casadio C, Zoboli S, Siccardi AG, Veronesi U (1999) Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med 26(4):348-357
49. Park SI, Shenoi J, Frayo SM, Hamlin DK, Lin Y, Wilbur DS, Stayton PS, Orgun N, Hylarides M, Buchegger F, Kenoyer AL, Axtman A, Gopal AK, Green DJ, Pagel JM, Press OW (2011) Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-Hodgkin lymphoma. Clin Cancer Res 17(23):7373-7382
50. Parrott MB, Adams KE, Mercier GT, Mok H, Campos SK, Barry MA (2003) Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol Ther 8(4):688-700
51. Pazy Y, Raboy B, Matto M, Bayer EA, Wilchek M, Livnah O (2003) Structure-based rational design of streptavidin mutants with pseudo-catalytic activity. J Biol Chem 278(9):7131-7134
52. Pereboeva L, Komarova S, Roth J, Ponnazhagan S, Curiel DT (2007) Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus. Gene Ther 14(8):627-637
53. Pierron J, Malan C, Creus M, Gradinaru J, Hafner I, Ivanova A, Sardo A, Ward TR (2008) Artificial metalloenzymes for asymmetric allylic alkylation on the basis of the biotin-avidin technology. Angew Chem Int Ed Engl 47(4):701-705
54. Pizzato M, Blair ED, Fling M, Kopf J, Tomassetti A, Weiss RA, Takeuchi Y (2001) Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Gene Ther 8(14):1088-1096
55. Popp MW, Karssemeijer RA, Ploegh HL (2012) Chemoenzymatic site-specific labeling of influenza glycoproteins as a tool to observe virus budding in real time. PLoS Pathog 8(3):e1002604
56. Pordea A, Creus M, Panek J, Duboc C, Mathis D, Novic M, Ward TR (2008) Artificial metalloenzyme for enantioselective sulfoxidation based on vanadyl-loaded streptavidin. J Am Chem Soc 130(25):8085-8088
57. Pordea A, Creus M, Letondor C, Ivanova A, Ward TR (2010) Improving the enantioselectivity of artificial transfer hydrogenases based on the biotin-streptavidin technology by combinations of point mutations. Inorg Chim Acta 363(3):601-604
58. Purow B, Staveley-O'Carroll K (2005) Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies. J Surg Res 123(1):49-54
59. Raiteri R, Grattarola M, Butt HJ, Skladal P (2001) Micromechanical cantilever-based biosensors. Sensors Actuators B Chem 79(2-3):115-126
60. Reetz MT, Rentzsch M, Pletsch A, Maywald M, Maiwald P, Peyralans JJP, Maichele A, Fu Y, Jiao N, Hollmann F, Mondiere R, Taglieber A (2007) Directed evolution of enantioselective hybrid catalysts: a novel concept in asymmetric catalysis. Tetrahedron 63(28):6404-6414
61. Rhee HW, Zou P, Udeshi ND, Martell JD, Mootha VK, Carr SA, Ting AY (2013) Proteomic mapping of mitochondria in living cells via spatially restricted enzymatic tagging. Science 339(6125):1328-1331
62. Rinne J, Albarran B, Jylhava J, Ihalainen TO, Kankaanpaa P, Hytonen VP, Stayton PS, Kulomaa MS, Vihinen-Ranta M (2007) Internalization of novel non-viral vector TAT-streptavidin into human cells. BMC Biotechnol 7:1
63. Ruigrok VJB, van Duijn E, Barendregt A, Dyer K, Tainer JA, Stoltenburg R, Strehlitz B, Levisson M, Smidt H, van der Oost J (2012) Kinetic and stoichiometric characterisation of streptavidin-binding aptamers. Chembiochem 13(6):829-836
64. Sakahara H, Saga T (1999) Avidin-biotin system for delivery of diagnostic agents. Adv Drug Deliv Rev 37(1-3):89-101
65. Sano T, Vajda S, Reznik GO, Smith CL, Cantor CR (1996) Molecular engineering of streptavidin. Ann N Y Acad Sci 799:383-390
66. Shoaib M, Kulyyassov A, Robin C, Winczura K, Tarlykov P, Despas E, Kannouche P, Ramanculov E, Lipinski M, Ogryzko V (2013) PUB-NChIP - "in vivo biotinylation" approach to study chromatin in proximity to a protein of interest. Genome Res 23(2):331-340
67. Skerra A, Schmidt TGM (2000) Use of the Strep-tag and streptavidin for detection and purification of recombinant proteins. Appl Chim Genes Hybrid Proteins Pt A 326:271-304
68. Srisawat C, Engelke DR (2001) Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins. RNA 7(4):632-641
69. Suk JS, Suh J, Choy K, Lai SK, Fu J, Hanes J (2006) Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles. Biomaterials 27(29):5143-5150
70. Sun W, Fletcher D, van Heeckeren RC, Davis PB (2012) Non-covalent ligand conjugation to biotinylated DNA nanoparticles using TAT peptide genetically fused to monovalent streptavidin. J Drug Target 20(22845840):678-690
71. Tagwerker C, Flick K, Cui M, Guerrero C, Dou Y, Auer B, Baldi P, Huang L, Kaiser P (2006) A tandem affinity tag for two-step purification under fully denaturing conditions: application in ubiquitin profiling and protein complex identification combined with in vivocross-linking. Mol Cell Proteomics 5(4):737-748
72. Takakura Y, Tsunashima M, Suzuki J, Usami S, Kakuta Y, Okino N, Ito M, Yamamoto T (2009) Tamavidins - novel avidin-like biotin-binding proteins from the Tamogitake mushroom. FEBS J 276(5):1383-1397
73. Takakura Y, Sofuku K, Tsunashima M (2013) Tamavidin 2-REV: an engineered tamavidin with reversible biotin-binding capability. J Biotechnol 164(1):19-25
74. Tanaka K, Yokoi S, Morimoto K, Iwata T, Nakamoto Y, Nakayama K, Koyama K, Fujiwara T, Fukase K (2012) Cell surface biotinylation by azaelectrocyclization: easy-handling and versatile approach for living cell labeling. Bioorg Med Chem 20(6):1865-1868
75. Tannous BA, Grimm J, Perry KF, Chen JW, Weissleder R, Breakefield XO (2006) Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat Methods 3(5):391-396
76. Taylor SK, Wang J, Kostic N, Stojanovic MN (2013) Monovalent streptavidin that senses oligonucleotides. Angew Chem Int Ed Engl 52(21):5509-5512
77. Tenzer S, Moro A, Kuharev J, Francis AC, Vidalino L, Provenzani A, Macchi P (2013) Proteome-wide characterization of the RNA-binding protein RALY-interactome using the in Vivo-Biotinylation-Pulldown-Quant (iBioPQ) Approach. J Proteome Res 12(6):2869-2884
78. Torchilin VP, Rammohan R, Weissig V, Levchenko TS (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A 98(15):8786-8791
79. van Werven FJ, Timmers HT (2006) The use of biotin tagging in Saccharomyces cerevisiae improves the sensitivity of chromatin immunoprecipitation. Nucleic Acids Res 34(4):e33
80. Waehler R, Russell SJ, Curiel DT (2007) Engineering targeted viral vectors for gene therapy. Nat Rev Genet 8(8):573-587
81. Wang C, Yang G, Luo Z, Ding H (2009) In vitro selection of high-affinity DNA aptamers for streptavidin. Acta Biochim Biophys Sin (Shanghai) 41(4):335-340
82. Ward TR (2011) Artificial metalloenzymes based on the biotin-avidin technology: enantioselective catalysis and beyond. Acc Chem Res 44(1):47-57
83. Weber PC, Ohlendorf DH, Wendoloski JJ, Salemme FR (1989) Structural origins of high-affinity biotin binding to streptavidin. Science 243(4887):85-88
84. Wilchek M, Bayer EA (1988) The avidin-biotin complex in bioanalytical applications. Anal Biochem 171(1):1-32
85. Wilchek M, Bayer EA, Livnah O (2006) Essentials of biorecognition: the (strept)avidin-biotin system as a model for protein-protein and protein-ligand interaction. Immunol Lett 103(1):27-32
86. Wollscheid B, Bausch-Fluck D, Henderson C, O'Brien R, Bibel M, Schiess R, Aebersold R, Watts JD (2009) Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol 27(4):378-386
87. Wu SC, Wong SL (2005) Engineering soluble monomeric streptavidin with reversible biotin binding capability. J Biol Chem 280(24):23225-23231
88. Xia CF, Boado RJ, Pardridge WM (2009) Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. Mol Pharm 6(3):747-751
89. Yumura K, Ui M, Doi H, Hamakubo T, Kodama T, Tsumoto K, Sugiyama A (2013) Mutations for decreasing the immunogenicity and maintaining the function of core streptavidin. Protein Sci 22(23225702):213-221
90. Zeidan Q, Hart GW (2010) The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 123(Pt 1):13-22
91. Zimbron JM, Heinisch T, Schmid M, Hamels D, Nogueira ES, Schirmer T, Ward TR (2013) A dual anchoring strategy for the localization and activation of artificial metalloenzymes based on the biotin-streptavidin technology. J Am Chem Soc 135(14):5384-5388
92. Zola H, Swart B, Banham A, Barry S, Beare A, Bensussan A, Boumsell L, Buckley C, Buhring HJ, Clark G, Engel P, Fox D, Jin BQ, Macardle PJ, Malavasi F, Mason D, Stockinger H, Yang X (2007) CD molecules 2006 - human cell differentiation molecules. J Immunol Methods 319(1-2):1-5